SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-012901
Filing Date
2022-04-04
Accepted
2022-04-04 16:10:10
Documents
13
Period of Report
2022-04-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20003735x1_8k.htm   iXBRL 8-K 37847
2 EXHIBIT 2.1 ny20003735x1_ex2-1.htm EX-2.1 985956
  Complete submission text file 0001140361-22-012901.txt   1348025

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cstl-20220404.xsd EX-101.SCH 3950
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cstl-20220404_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cstl-20220404_pre.xml EX-101.PRE 16060
7 EXTRACTED XBRL INSTANCE DOCUMENT ny20003735x1_8k_htm.xml XML 4236
Mailing Address 505 S FRIENDSWOOD DRIVE SUITE 401 FRIENDSWOOD TX 77546
Business Address 505 S FRIENDSWOOD DRIVE SUITE 401 FRIENDSWOOD TX 77546 866-788-9007
CASTLE BIOSCIENCES INC (Filer) CIK: 0001447362 (see all company filings)

IRS No.: 770701774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38984 | Film No.: 22802229
SIC: 8071 Services-Medical Laboratories